{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=MATCH&page=14", "query": { "intervention": "MATCH", "page": 14 }, "page_size": 10 }, "pagination": { "page": 14, "page_size": 10, "total_count": 9963, "total_pages": 997, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=MATCH&page=15&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=MATCH&page=13&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T15:43:20.591Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06383390", "title": "The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atherosclerotic Cardiovascular Disease (ASCVD)", "Chronic Kidney Disease (CKD)" ], "interventions": [ { "name": "Retatrutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 10000, "start_date": "2024-04-30", "completion_date": "2029-02", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-10-21T15:43:20.591Z", "location_count": 204, "location_summary": "Alabaster, Alabama • Birmingham, Alabama • Daphne, Alabama + 159 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Daphne", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT06383390" }, { "nct_id": "NCT03037580", "title": "Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Hypertension", "Heart Failure With Preserved Ejection Fraction" ], "interventions": [ { "name": "Oral treprostinil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "United Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 84, "start_date": "2017-08-15", "completion_date": "2019-12-03", "has_results": true, "last_update_posted_date": "2020-11-10", "last_synced_at": "2026-10-21T15:43:20.591Z", "location_count": 82, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 66 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03037580" }, { "nct_id": "NCT05364762", "title": "Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Chronic Myelomonocytic Leukemia", "Myelodysplastic Syndrome", "Myeloproliferative Neoplasm", "Primary Myelofibrosis", "Secondary Myelofibrosis" ], "interventions": [ { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Itacitinib", "type": "DRUG" }, { "name": "Peripheral Blood Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Tacrolimus", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "80 Years", "sex": "ALL", "summary": "Up to 80 Years" }, "enrollment_count": 20, "start_date": "2022-12-29", "completion_date": "2027-03-25", "has_results": false, "last_update_posted_date": "2026-10-14", "last_synced_at": "2026-10-21T15:43:20.591Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05364762" }, { "nct_id": "NCT05056727", "title": "A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Renal Insufficiency, Chronic", "Hyperkalemia" ], "interventions": [ { "name": "Sodium Zirconium Cyclosilicate (SZC)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Lisinopril", "type": "DRUG" }, { "name": "Valsartan", "type": "DRUG" }, { "name": "Irbesartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 1112, "start_date": "2021-09-30", "completion_date": "2024-02-07", "has_results": true, "last_update_posted_date": "2026-01-08", "last_synced_at": "2026-10-21T15:43:20.591Z", "location_count": 42, "location_summary": "Surprise, Arizona • Tucson, Arizona • Canyon Country, California + 36 more", "locations": [ { "city": "Surprise", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Canyon Country", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "Northridge", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05056727" }, { "nct_id": "NCT05218642", "title": "To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alopecia", "Male Pattern Hair Loss" ], "interventions": [ { "name": "KX- 826 dosed at 2.5mg", "type": "DRUG" }, { "name": "KX-826 dosed at 5mg", "type": "DRUG" }, { "name": "Matching placebo to KX-826", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Suzhou Kintor Pharmaceutical Inc,", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "MALE", "summary": "18 Years to 70 Years · Male only" }, "enrollment_count": 123, "start_date": "2022-01-31", "completion_date": "2023-02-13", "has_results": false, "last_update_posted_date": "2023-11-22", "last_synced_at": "2026-10-21T15:43:20.591Z", "location_count": 10, "location_summary": "Fountain Valley, California • Hialeah, Florida • Hialeah Gardens, Florida + 7 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Hialeah Gardens", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Palmetto Bay", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05218642" }, { "nct_id": "NCT01007942", "title": "Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HER2/Neu Over-expressing Locally Advanced Breast Cancer", "Metastatic Breast Cancer" ], "interventions": [ { "name": "everolimus", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "vinorelbine", "type": "DRUG" }, { "name": "trastuzumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 569, "start_date": "2009-10", "completion_date": "2015-06", "has_results": true, "last_update_posted_date": "2017-04-05", "last_synced_at": "2026-10-21T15:43:20.591Z", "location_count": 43, "location_summary": "Tucson, Arizona • La Jolla, California • Greenwood Village, Colorado + 30 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Greenwood Village", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01007942" }, { "nct_id": "NCT01008423", "title": "Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Proctitis", "Proctosigmoiditis" ], "interventions": [ { "name": "Budesonide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bausch Health Americas, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 281, "start_date": "2009-11-20", "completion_date": "2013-03-18", "has_results": true, "last_update_posted_date": "2019-08-14", "last_synced_at": "2026-10-21T15:43:20.591Z", "location_count": 62, "location_summary": "Dothan, Alabama • Mesa, Arizona • Tucson, Arizona + 59 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01008423" }, { "nct_id": "NCT01297062", "title": "A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Subjects" ], "interventions": [ { "name": "Exenatide", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Placebo comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 94, "start_date": "2011-02", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2015-04-14", "last_synced_at": "2026-10-21T15:43:20.591Z", "location_count": 2, "location_summary": "Daytona Beach, Florida • Evansville, Indiana", "locations": [ { "city": "Daytona Beach", "state": "Florida" }, { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01297062" }, { "nct_id": "NCT05022303", "title": "AT1001 for the Treatment of COVID-19 Related MIS-C", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Covid19", "Multisystem Inflammatory Syndrome in Children" ], "interventions": [ { "name": "Larazotide Acetate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "21 Years", "sex": "ALL", "summary": "1 Month to 21 Years" }, "enrollment_count": 12, "start_date": "2021-10-01", "completion_date": "2024-05-15", "has_results": false, "last_update_posted_date": "2024-06-13", "last_synced_at": "2026-10-21T15:43:20.591Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05022303" }, { "nct_id": "NCT02036970", "title": "Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pulmonary Arterial Hypertension", "Pulmonary Hypertension", "Interstitial Lung Disease", "Idiopathic Interstitial Pneumonia", "Idiopathic Pulmonary Fibrosis", "Sarcoidosis", "Respiratory Bronchiolitis Associated Interstitial Lung Disease", "Desquamative Interstitial Pneumonia", "Cryptogenic Organizing Pneumonia", "Acute Interstitial Pneumonitis", "Idiopathic Lymphoid Interstitial Pneumonia", "Idiopathic Pleuroparenchymal Fibroelastosis" ], "interventions": [ { "name": "Bardoxolone methyl", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 166, "start_date": "2014-05-31", "completion_date": "2018-05-16", "has_results": true, "last_update_posted_date": "2025-06-10", "last_synced_at": "2026-10-21T15:43:20.591Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Beverly Hills, California • Los Angeles, California + 20 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02036970" } ] }